Speaker: Lilli Zakarija
Date: May 5, 2017
Event: Drug Development & Delivery Innovation Networking Summit
EdgeOne Medical President Lilli Zakarija provides an overview of the key issues and topics regarding Device Design Controls when using an Off-The-Shelf (OTS) Device versus a Custom Developed Device to a diverse crowd of Biopharma executives.
Leading Device Qualification for Delivery System of Biologic for Phase II Clinical Study while Leveraging EdgeOne Medical QMS
Conducting Design Verification and Validation Testing on Custom Device
Access the EdgeOne Medical Combination Product Development & Testing Blog